Immediate Impact
6 from Science/Nature 60 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of Kyle S. McCommis being referenced
The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
2023
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kyle S. McCommis | 1039 | 440 | 370 | 67 | 2.0k | |
| Tohru Yamamori | 1376 | 632 | 331 | 56 | 2.7k | |
| Yasuhiro Irino | 1060 | 373 | 225 | 62 | 2.0k | |
| Beat M. Jucker | 1114 | 682 | 353 | 56 | 2.5k | |
| Bert Binas | 1483 | 517 | 190 | 67 | 2.3k | |
| Yoshishige Urata | 1320 | 293 | 192 | 70 | 2.6k | |
| Jun Yoshioka | 1527 | 439 | 214 | 50 | 2.4k | |
| Hideru Obinata | 1745 | 423 | 161 | 50 | 2.6k | |
| Julien Hanson | 1004 | 406 | 161 | 63 | 2.2k | |
| Margaret C. Cam | 975 | 341 | 268 | 57 | 2.4k | |
| Jane McHowat | 1515 | 474 | 257 | 101 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...